Pharmaceutical giant Merck confirmed this week that it has appointed Ashley Watson as chief ethics and compliance officer, effective April 1. She will report to Chief Executive Kenneth Frazier.
Watson will replace Michael Holston, who will assume the general counsel role from Bruce Kuhlik, who is retiring. Holston’s appointment becomes effective July 1, 2015.
